n8n versions before 1.123.80, from 2.0.0 before 2.39.6, and from 2.40.0 before 2.40.1 contain a path traversal vulnerability in signed resume URL generation for Send-and-Wait approvals. Attackers with workflow creation permissions can mint valid approval URLs for gates in projects they cannot access by exploiting unresolved traversal sequences in caller-controlled node IDs, enabling cross-project approval forgery.
0.3%(unchanged from 0.3% a week ago; 0.3% 30 days ago) estimated probability of exploitation activity in the next 30 days; 21st percentile. Scored 2026-11-17. A forecast for this CVE across the internet, not for your own systems.
CISA's assessment (SSVC)
Exploitation: none · Automatable: no · Technical impact: partial, assessed 2026-10-06. From CISA's Vulnrichment in the CVE List: whether it is exploited, whether exploiting it can be automated, and how much control it gives.
CWE
CWE-22Improper Limitation of a Pathname to a Restricted Directory (Path traversal)
Show the promptExplain CVE-2026-103254 for an engineer deciding whether to act. Use https://cve.bz/api/public/cves/CVE-2026-103254?via=ask-ai-copy and https://cve.bz/cve/CVE-2026-103254?via=ask-ai-copy as the source of truth: what is affected and which versions fix it, whether it is in CISA KEV, public exploits, and its EPSS (an internet-wide 30-day estimate of exploitation activity, not a forecast for my systems). If they give no fixed versions, use the CVE record https://cveawg.mitre.org/api/cve/CVE-2026-103254 or the vendor advisory, not third-party mirrors. Tell me how to check whether I am affected and how to verify a fix. Cite the sources and say where they are uncertain.
Opens a third-party assistant; its answer is its own, not cve.bz's. The prompt holds only this CVE's id and public links.